Sternchemie has received a GRAS “letter of no objection” from the US Food and Drug Administration (FDA) for its wide range of sunflower lecithins. GRAS stands for “Generally Recognised As Safe” and provides certainty and transparency for food manufacturers. With this determination, the FDA confirms that sunflower lecithin from Sternchemie, whether liquid, de-oiled or hydrolysed, can safely be used in a wide variety of food products.
FDA to Phase Out Animal Testing Requirement for Some Drugs in “Win for Public Health & Ethics”
The U.S. Food and Drug Administration (FDA) has announced it will be phasing out animal testing in the development of monoclonal antibody therapies and some other drugs, in what has been described as a “groundbreaking step to advance public health”. Animal testing will be replaced with more effective, human-relevant methods, including AI-based computational models of toxicity and cell lines along with organoid toxicity testing in a laboratory setting. Where a drug has already been tested in humans, the FDA will also use pre-existing, real-world safety data from other countries with comparable regulatory standards. The new regimen will begin immediately for investigational new drug (IND) applications. The approach is designed to improve drug safety, accelerate the evaluation process, reduce animal experimentation, lower research and development costs, …